NPJ precision oncology.
Saved in:
| VerfasserIn: | |
|---|---|
| TeilnehmendeR: | |
| Place / Publishing House: | [London] : : Springer Nature,, [2017]- |
| Publication history: | Began with 1:1 (2017). |
| Language: | English |
| Physical Description: | 1 online resource |
| Notes: | Refereed/Peer-reviewed |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
- Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
- Precision oncology- the future of personalized cancer medicine?
- Circulating tumor cells: quintessential precision oncology presenting challenges for biology
- Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
- EBV based cancer prevention and therapy in nasopharyngeal carcinoma
- Endothelial cell malignancies: new insights from the laboratory and clinic
- Revisiting the IGF-1R as a breast cancer target
- Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
- Targeting the duality of cancer
- Network-based machine learning and graph theory algorithms for precision oncology
- Immune cell profiling in cancer: molecular approaches to cell-specific identification
- Addressing the challenges of applying precision oncology
- Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
- Towards personalized tumor markers
- Erratum: Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.